EL.En. S.p.A. (ELN.MI) stock analysis
In our weekly check, EL.En. S.p.A. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 17 pass, warnings: 3, red flags: 4.
About EL.En. S.p.A.
EL.En. S.p.A. is a Healthcare company (Medical - Devices) based in Italy, listed on MIL as ELN.MI.
What our checks show for ELN.MI
Red flags
- Analysts expect revenue to shrink about 6.8% a year.
- The stock has fallen as much as 76% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 3.3 years.
- Thinly traded (about 42 thousand shares a day): buying and selling can move the price.
Warning signs
- Analysts expect earnings per share to shrink about 8.7% a year.
- Revenue grew only 0.7% a year over the last 3 years.
- A small company (market value $1.48 billion): usually riskier and followed by fewer analysts.
Strengths
- Debt is low: 0.03x equity.
- The net margin rose by 2.5 points over 5 years, to 10.5%.
- Earnings per share grew 18.6% a year over the last 3 years.
- The dividend takes 0% of profit: there is a cushion.
- The price is 14.5 times earnings (P/E), reasonable for its growth.
- Return on capital (ROCE) is 22%: the business earns well on the money put into it.
Similar companies
PRCT · NVCR · TNDM · LMRI · CNMD · ENOV
Questions
What grade does EL.En. S.p.A. (ELN.MI) have?
In our weekly check, EL.En. S.p.A. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 17 pass, warnings: 3, red flags: 4. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of ELN.MI stock?
This week's biggest flags for EL.En. S.p.A.: Weak revenue forecast, Deep past fall, Slow recovery after falls. In total 7 of 24 checks show a warning or a red flag.
What does EL.En. S.p.A. do?
EL.En. S.p.A. is a Healthcare company (Medical - Devices) based in Italy, listed on MIL as ELN.MI.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis